Navigation Links
For many prostate cancer patients, Web sites are too difficult to read
Date:10/29/2012

MAYWOOD, IL - Ninety million American adults read below high school levels, so the National Institutes of Health recommends that patient-education materials be written at the fourth-through-six grade level.

But a Loyola University Medical Center study has found that only 4.8 percent of web sites describing prostate cancer were written below a high school reading level. The median reading level was 12th grade.

"This is probablematic for one-third of Americans who seek to further educate themselves using online resources," senior author Gopal Gupta, MD and colleagues wrote. The study is published online ahead of print in the Journal of Urology.

Gupta and colleagues identified 62 web sites by searching for "prostate cancer" "prostate cancer treatment" and "prostatectomy" on Google, Yahoo and Bing search engines. Researchers used word processing software to test the readability of the first 300 words of each web site.

To assess readability, researchers used the Flesch-Kincaid test, which measures the reading grade level, and the Flesch reading ease test, which assigns a readability score of 0 to 100. The tests are based on formulas that incorporate total number of words, sentences and syllables.

Sixty-three percent of the sites were written above a 12th grade reading level, and the median Flesch reading ease score for all sites a relatively difficult 38.1. (The Flesch reading ease score ranges from 0 to 100. A web site with a score of 90 to 100 would be easily understood by an 11-year-old; a score of 60-to-70 would be understood by 13-to-15-year-olds; and scores lower than 30 would be suited to college grads.)

Web sites with the easiest readability scores were News-Medical Net (8th grade level), Consumer Reports.org (8.9), Family Doctor.org (8.95), UPMC Cancer Centers (9.2) and NIH Pubmed Health (9.8).

"It was discouraging to find that only 4.8 percent of these sites had information written for those below a high school reading level," Gupta and colleagues wrote. "No sites in our study were written at the level recommended by the NIH (4-6th grade). Given that nearly one-third of the U.S. population reads below high school level, this raises the concern that many patients will have difficulty comprehending online information about prostate cancer treatment options."

Prostate cancer is among the more difficult topics for patients to comprehend. There are at least four options (surgery, radiation beam therapy, radiation seeds and active surveillance). Each option has pros and cons, which vary according to the patient's age, tumor type, overall health, etc. Doctors may find it difficult to simplify technology-based treatments, anatomical descriptions and medical terminology. And some terms doctors take for granted, such as "erection" and "impotent," might not be understood by patients with low health literacy.

Researchers concluded: "Clinicians should be aware that some of their patients may not be able to read online information and should consciously guide patients with low literacy to not only high-quality web sites, but also sites that are easy-to-read, to prevent confusion and anxiety after being diagnosed with prostate cancer."

Dr. Gupta is an instructor in the Departments of Urology and Surgery and the Oncology Institute of Loyola University Chicago Stritch School of Medicine. His special interests include urologic oncology and robotic and minimally invasive surgery.

Co-authors are of the readability study are Chandy Ellimoottil, MD, (first author); Anthony Polcari, MD; and Adam Kadlec, MD.


'/>"/>
Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Viagra Can Help Prostate Cancer Patients Maintain Sex Lives: Study
2. Drop in testosterone tied to prostate cancer recurrence
3. Moffitt Researchers find genetic predictors of fatigue for some prostate cancer patients
4. First web-based prostate cancer database launches
5. Lab Contamination Behind Debunked Link Between Virus, Prostate Cancer
6. Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
7. Cloned receptor paves way for new breast and prostate cancer treatment
8. Drug Used to Prevent Prostate Cancer Wont Lower Quality of Life
9. Taking Breaks From Prostate Cancer Hormone Therapy Seems Safe: Study
10. Norwich Research Park Prostate Cancer Initiative wins major award
11. FDA OKs Drug for Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... ... Michael Vick announced his retirement earlier this year from the NFL after thirteen ... in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro Bowl appearances ... yards by a quarterback (6,109) and the most rushing yards by a quarterback in ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Sean Fay ... Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold ... any other marketer in the last 25 years. , Now, due to changes in ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... -- New research provides evidence that an old drug may provide ... released today that will be presented at the American ... Boston , April 22 to 28, 2017. ... the oral drug levodopa has long been considered the gold ... disease progresses, the effects of the medication can partially wear ...
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: